Health Sciences Acquisitions Co. 2 (HSAQ) Competitors $4.40 -0.20 (-4.35%) As of 03/28/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesSEC FilingsTrendsBuy This Stock HSAQ vs. ARAY, UTMD, DRTS, BWAY, SKIN, OBIO, TLSI, CATX, LNSR, and PDEXShould you be buying Health Sciences Acquisitions Co. 2 stock or one of its competitors? The main competitors of Health Sciences Acquisitions Co. 2 include Accuray (ARAY), Utah Medical Products (UTMD), Alpha Tau Medical (DRTS), BrainsWay (BWAY), Beauty Health (SKIN), Orchestra BioMed (OBIO), TriSalus Life Sciences (TLSI), Perspective Therapeutics (CATX), LENSAR (LNSR), and Pro-Dex (PDEX). These companies are all part of the "surgical & medical instruments" industry. Health Sciences Acquisitions Co. 2 vs. Accuray Utah Medical Products Alpha Tau Medical BrainsWay Beauty Health Orchestra BioMed TriSalus Life Sciences Perspective Therapeutics LENSAR Pro-Dex Accuray (NASDAQ:ARAY) and Health Sciences Acquisitions Co. 2 (NASDAQ:HSAQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment, dividends and community ranking. Which has more volatility and risk, ARAY or HSAQ? Accuray has a beta of 1.46, indicating that its share price is 46% more volatile than the S&P 500. Comparatively, Health Sciences Acquisitions Co. 2 has a beta of 0.09, indicating that its share price is 91% less volatile than the S&P 500. Is ARAY or HSAQ more profitable? Health Sciences Acquisitions Co. 2 has a net margin of 0.00% compared to Accuray's net margin of -0.96%. Health Sciences Acquisitions Co. 2's return on equity of 0.00% beat Accuray's return on equity.Company Net Margins Return on Equity Return on Assets Accuray-0.96% -9.75% -0.93% Health Sciences Acquisitions Co. 2 N/A N/A -2.38% Which has better earnings & valuation, ARAY or HSAQ? Health Sciences Acquisitions Co. 2 has lower revenue, but higher earnings than Accuray. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAccuray$453.14M0.41-$15.55M-$0.05-35.70Health Sciences Acquisitions Co. 2N/AN/A-$380KN/AN/A Does the MarketBeat Community believe in ARAY or HSAQ? Accuray received 335 more outperform votes than Health Sciences Acquisitions Co. 2 when rated by MarketBeat users. CompanyUnderperformOutperformAccurayOutperform Votes33565.56% Underperform Votes17634.44% Health Sciences Acquisitions Co. 2N/AN/A Do insiders and institutionals believe in ARAY or HSAQ? 64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.7% of Health Sciences Acquisitions Co. 2 shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 21.9% of Health Sciences Acquisitions Co. 2 shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth. Does the media refer more to ARAY or HSAQ? In the previous week, Accuray had 3 more articles in the media than Health Sciences Acquisitions Co. 2. MarketBeat recorded 3 mentions for Accuray and 0 mentions for Health Sciences Acquisitions Co. 2. Accuray's average media sentiment score of 0.93 beat Health Sciences Acquisitions Co. 2's score of 0.00 indicating that Accuray is being referred to more favorably in the media. Company Overall Sentiment Accuray Positive Health Sciences Acquisitions Co. 2 Neutral SummaryAccuray beats Health Sciences Acquisitions Co. 2 on 6 of the 11 factors compared between the two stocks. Remove Ads Get Health Sciences Acquisitions Co. 2 News Delivered to You Automatically Sign up to receive the latest news and ratings for HSAQ and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSAQ vs. The Competition Export to ExcelMetricHealth Sciences Acquisitions Co. 2Surgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$49.33M$4.33B$5.61B$7.68BDividend YieldN/A48.03%5.33%4.02%P/E RatioN/A28.1123.5018.55Price / SalesN/A48.63376.0088.66Price / CashN/A51.0838.1734.64Price / Book-7.106.036.814.11Net Income-$380,000.00$67.64M$3.20B$247.18M7 Day Performance-2.44%-6.55%-5.42%-4.05%1 Month Performance-3.30%-5.38%-0.12%-6.41%1 Year Performance-16.51%8.92%7.61%-2.08% Health Sciences Acquisitions Co. 2 Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSAQHealth Sciences Acquisitions Co. 2N/A$4.40-4.3%N/A-16.5%$49.33MN/A0.004ARAYAccuray2.6487 of 5 stars$1.90+2.2%N/A-26.3%$195.38M$453.14M-38.001,040Analyst DowngradeNews CoverageUTMDUtah Medical Products2.7317 of 5 stars$57.04+0.4%N/A-21.0%$193.48M$40.90M14.44180Positive NewsDRTSAlpha Tau Medical2.0855 of 5 stars$2.70+3.4%$8.00+196.3%-13.2%$188.80MN/A-6.2880Short Interest ↑News CoverageBWAYBrainsWay3.0963 of 5 stars$9.77-1.4%$13.17+34.8%+75.8%$183.94M$41.02M97.71120Short Interest ↑Gap DownSKINBeauty Health1.9327 of 5 stars$1.41+7.6%$2.50+77.3%-70.3%$175.01M$334.29M-3.361,030Gap UpOBIOOrchestra BioMed1.9249 of 5 stars$4.57+1.3%$15.40+237.0%-16.5%$173.72M$2.65M-2.844Positive NewsTLSITriSalus Life Sciences3.478 of 5 stars$5.67+0.5%$11.56+103.9%-42.4%$172.90M$26.89M-2.28106Earnings ReportAnalyst ForecastNews CoverageHigh Trading VolumeCATXPerspective Therapeutics2.7033 of 5 stars$2.52flat$14.56+477.6%N/A$170.32M$1.43M0.0070Analyst ForecastAnalyst RevisionLNSRLENSAR0.7025 of 5 stars$14.24-3.9%$15.00+5.3%+316.0%$167.88M$53.49M-9.75110High Trading VolumePDEXPro-Dex1.3423 of 5 stars$50.00+2.2%$52.00+4.0%+174.0%$163.05M$61.00M24.88140 Remove Ads Related Companies and Tools Related Companies Accuray Competitors Utah Medical Products Competitors Alpha Tau Medical Competitors BrainsWay Competitors Beauty Health Competitors Orchestra BioMed Competitors TriSalus Life Sciences Competitors Perspective Therapeutics Competitors LENSAR Competitors Pro-Dex Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HSAQ) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Sciences Acquisitions Co. 2 Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Sciences Acquisitions Co. 2 With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HSAQ Stock Free HSAQ Stock Alerts